Todd D. Gould

Performance on a virtual reality spatial memory navigation task in depressed patients.

Neil Burgess, Daniel S Pine, Neda F Gould, 2007, The American journal of psychiatry.

A Randomized Trial of the N-methyl-d-aspartate Receptor Glycine Site Antagonist Prodrug 4-chlorokynurenine in Treatment-Resistant Depression.

Jennifer W. Evans, D. Greenstein, T. Gould, 2020, The international journal of neuropsychopharmacology.

Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion

C. Mazucanti, R. Moaddel, B. Kadriu, 2023, iScience.

The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition

R. Schwarcz, T. Gould, C. Zarate, 2015, The Journal of Pharmacology and Experimental Therapeutics.

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers.

J. Gilbert, P. Zanos, Patrick J. Morris, 2024, Clinical pharmacology and therapeutics.

Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions

P. Zanos, Jaclyn N. Highland, R. Moaddel, 2024, Neuropharmacology.

Targeting metaplasticity mechanisms to promote sustained antidepressant actions.

Todd D. Gould, Kyle A Brown, Kyle A. Brown, 2024, Molecular psychiatry.